In vitro study of magnetite-amyloid β complex formation

Mònica Mir1,2, Islam Bogachan Tahirbegi1,3, Juan José Valle-Delgado1,4,5, Xavier Fernàndez-Busquets1,4,5, Josep Samitier1,2,3
1Nanobioengineering group, Institute for Bioengineering of Catalonia (IBEC), Barcelona, Spain
2Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina. (CIBER-BBN), Barcelona, Spain
3Department of Electronics, University of Barcelona, Barcelona, Spain
4Biomolecular Interactions Team, Nanoscience and Nanotechnology Institute (IN2UB), University of Barcelona, Barcelona, Spain
5Barcelona Centre for International Health Research CRESIB, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain

Tài liệu tham khảo

Goodman, 1953, Alzheimer's disease: a clinico-pathologic analysis of twenty-three cases with a theory on pathogenesis, J Nerv Ment Dis, 118, 97, 10.1097/00005053-195308000-00001 Ke, 2003, Iron misregulation in the brain: a primary cause of neurodegenerative disorders, Lancet Neurol, 2, 246, 10.1016/S1474-4422(03)00353-3 Zecca, 2004, Iron, brain ageing and neurodegenerative disorders, Nat Rev Neurosci, 5, 863, 10.1038/nrn1537 Smith, 1997, Iron accumulation in Alzheimer disease is a source of redox-generated free radicals, Proc Natl Acad Sci U S A, 94, 9866, 10.1073/pnas.94.18.9866 Khan, 2006, Redox cycling of iron by Abeta42, Free Radic Biol Med, 40, 557, 10.1016/j.freeradbiomed.2005.09.013 Kirschvink, 1992, Magnetite biomineralization in the human brain, Proc Natl Acad Sci U S A, 89, 7683, 10.1073/pnas.89.16.7683 Hautot, 2003, Preliminary evaluation of nanoscale biogenic magnetite in Alzheimer's disease brain tissue, Proc R Soc Lond B (Suppl), 270, S62, 10.1098/rsbl.2003.0012 Pankhurst, 2008, Increased levels of magnetic iron compounds in Alzheimer's disease, J Alzheimers Dis, 13, 49, 10.3233/JAD-2008-13105 Collingwood, 2008, Three-dimensional tomographic imaging and characterization of iron compounds within Alzheimer's plaque core material, J Alzheimers Dis, 14, 235, 10.3233/JAD-2008-14211 Cowley, 2000, The structure of ferritin cores determined by electron nanodiffraction, J Struct Biol, 131, 210, 10.1006/jsbi.2000.4292 Quintana, 2004, Electron nanodiffraction and high-resolution electron microscopy studies of the structure and composition of physiological and pathological ferritin, J Struct Biol, 147, 166, 10.1016/j.jsb.2004.03.001 Gálvez, 2008, Comparative structural and chemical studies of ferritin cores with gradual removal of their iron contents, J Am Chem Soc, 130, 8062, 10.1021/ja800492z Fisher, 1997, Blood transferrin and ferritin in Alzheimer's disease, Life Sci, 60, 2273, 10.1016/S0024-3205(97)00282-8 Zhang, 2008, Synthesis of carboxymethyl-chitosan-bound magnetic nanoparticles by the spraying co-precipitation method, Scr Mater, 59, 211, 10.1016/j.scriptamat.2008.03.006 Faiyas, 2010, Dependence of pH and surfactant effect in the synthesis of magnetite (Fe3O4) nanoparticles and its properties, J Magn Magn Mater, 322, 400, 10.1016/j.jmmm.2009.09.064 Sato, 2006, Development of new screening system for Alzheimer disease, in vitro Aβ sink assay, to identify the dissociation of soluble Aβ from fibrils, Neurobiol Dis, 22, 487, 10.1016/j.nbd.2005.12.010 Dahlgren, 2002, Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability, J Biol Chem, 277, 32046, 10.1074/jbc.M201750200 Gill, 1989, Calculation of protein extinction coefficients from amino acid sequence data, Anal Biochem, 182, 319, 10.1016/0003-2697(89)90602-7 Gaasch, 2007, Voltage-gated calcium channels provide an alternate route for iron uptake in neuronal cell cultures, Neurochem Res, 32, 1686, 10.1007/s11064-007-9313-1 Bishop, 2003, Human Aβ1-42 reduces iron-induced toxicity in rat cerebral cortex, J Neurosci Res, 73, 316, 10.1002/jnr.10661 Kuo, 1996, Water-soluble Aβ (N-40, N-42) oligomers in normal and alzheimer disease brains, J Biol Chem, 271, 4077, 10.1074/jbc.271.8.4077 Atwood, 2004, Copper mediates dityrosine cross-linking of Alzheimer's amyloid-β, Biochemistry, 43, 560, 10.1021/bi0358824 Chikazumi, 1997, 11 Lacheisserie, 2005, 80 Arimon, 2005, Fine structure study of Aβ1-42 fibrillogenesis with atomic force microscopy, FASEB J, 19, 1344, 10.1096/fj.04-3137fje Garzon-Rodriguez, 1999, Binding of Zn(II), Cu(II), and Fe(II) ions to Alzheimer's Aβ peptide studied by fluorescence, Bioorg Med Chem Lett, 9, 2243, 10.1016/S0960-894X(99)00357-1 Nakamura, 2007, Three histidine residues of amyloid-β peptide control the redox activity of copper and iron, Biochemistry, 46, 12737, 10.1021/bi701079z Dobson, 2001, Nanoscale biogenic iron oxides and neurodegenerative disease, FEBS Lett, 496, 1, 10.1016/S0014-5793(01)02386-9 Regazzoni, 1981, Some observations on the composition and morphology of synthetic magnetites obtained by different routes, J Inorg Nucl Chem, 43, 1489, 10.1016/0022-1902(81)80322-3 Harper, 1997, Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-β protein, Chem Biol, 4, 951, 10.1016/S1074-5521(97)90303-3 Treiber, 2005, Metals on the brain, Sci Aging Knowledge Environ, 36, e27